India’s fourth largest lab group, Thyrocare, will list in Mumbai on April 27. It hopes to raise INR 480 crore (US$ 72.2m) with shares priced at 420-446 rupees. Mauritian private equity group CX Partners will sell 90% of its holding and the rest is from the firm’s promoters.